Back to today’s briefing

Story perspectives

Genetic Testing Offers Hope for High-Risk Myeloma Patients

2/20/2025

31 7

Summary

Story summary

Researchers from the University of Leeds and The Institute of Cancer Research are urging genetic testing for multiple myeloma patients. Those with multiple genetic abnormalities face a daunting risk of rapid disease progression and early mortality. However, the OPTIMUM MUK 9 trial reveals that personalized treatments could offer hope and significantly enhance survival for these high-risk individuals.

1 of 1

Story summary

Researchers from the University of Leeds and The Institute of Cancer Research are urging genetic testing for multiple myeloma patients. Those with multiple genetic abnormalities face a daunting risk of rapid disease progression and early mortality. However, the OPTIMUM MUK 9 trial reveals that personalized treatments could offer hope and significantly enhance survival for these high-risk individuals.